First Trust Advisors LP Nektar Therapeutics Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$3.17 - $6.17 $10.9 Million - $21.2 Million	3,443,933 Added 78.44%	7,834,551 $29.8 Million
Q1 2022 May 13, 2022	BUY	$4.16 - $13.72 $4.04 Million - $13.3 Million	970,889 Added 28.39%	4,390,618 $23.7 Million
Q4 2021 Feb 08, 2022	SELL	$10.83 - $18.41 $4.08 Million - $6.93 Million	-376,587 Reduced 9.92%	3,419,729 $46.2 Million
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $7.07 Million - $10.2 Million	540,918 Added 16.62%	3,796,316 $68.2 Million
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $14.7 Million - $18.2 Million	-892,682 Reduced 21.52%	3,255,398 $55.9 Million
Q1 2021 May 14, 2021	BUY	$16.56 - $25.46 $5.53 Million - $8.5 Million	333,865 Added 8.75%	4,148,080 $83 Million
Q4 2020 Feb 02, 2021	BUY	$15.77 - $19.03 $12.5 Million - $15.1 Million	791,605 Added 26.19%	3,814,215 $64.8 Million
Q3 2020 Nov 05, 2020	SELL	$16.59 - $24.79 $6.25 Million - $9.33 Million	-376,435 Reduced 11.07%	3,022,610 $50.1 Million
Q2 2020 Jul 22, 2020	BUY	$16.86 - $23.44 $14.7 Million - $20.5 Million	874,810 Added 34.66%	3,399,045 $78.7 Million
Q1 2020 May 06, 2020	SELL	$14.47 - $27.96 $6.44 Million - $12.4 Million	-445,217 Reduced 14.99%	2,524,235 $45.1 Million
Q4 2019 Feb 03, 2020	BUY	$15.87 - $23.12 $4.96 Million - $7.22 Million	312,311 Added 11.75%	2,969,452 $64.1 Million
Q3 2019 Nov 04, 2019	SELL	$16.91 - $36.27 $5.9 Million - $12.7 Million	-348,858 Reduced 11.61%	2,657,141 $48.4 Million
Q2 2019 Jul 30, 2019	BUY	$31.0 - $36.3 $26.6 Million - $31.1 Million	856,819 Added 39.87%	3,005,999 $107 Million
Q1 2019 May 09, 2019	SELL	$31.58 - $46.35 $5.05 Million - $7.42 Million	-159,992 Reduced 6.93%	2,149,180 $72.2 Million
Q4 2018 Feb 07, 2019	BUY	$30.43 - $56.65 $7.31 Million - $13.6 Million	240,272 Added 11.61%	2,309,172 $75.9 Million
Q3 2018 Oct 25, 2018	BUY	$46.46 - $68.49 $61.3 Million - $90.4 Million	1,319,776 Added 176.18%	2,068,900 $126 Million
Q2 2018 Aug 02, 2018	BUY	$46.25 - $104.45 $797,442 - $1.8 Million	17,242 Added 2.36%	749,124 $36.6 Million
Q1 2018 Apr 23, 2018	SELL	$57.4 - $108.44 $55.9 Million - $106 Million	-973,750 Reduced 57.09%	731,882 $77.8 Million
Q4 2017 Feb 08, 2018	BUY	$23.02 - $60.5 $1.14 Million - $2.99 Million	49,422 Added 2.98%	1,705,632 $102 Million
Q3 2017 Oct 24, 2017	BUY	$17.79 - $24.0 $29.5 Million - $39.7 Million	1,656,210	1,656,210 $39.7 Million

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$14.8 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$14.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$12.2 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$8.74 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$8.56 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account